Cousins Properties (CUZ) Insider Files Form 144 to Sell 4,612 Shares
Rhea-AI Filing Summary
Cousins Properties Inc. (CUZ) filed a Form 144 notice reporting a proposed sale of 4,612 common shares for an aggregate market value of $133,932.00. The shares represent part of the company's outstanding common stock of 167,967,656 shares and are scheduled for sale on 09/05/2025 through Merrill Lynch (1 Cowboys Way, Frisco, TX) on the NYSE. The reported shares were acquired entirely as stock awards from the issuer on specific vesting dates between 01/31/2023 and 02/14/2025; the filing shows the payment/settlement as vesting. The filer certifies they are not aware of any undisclosed material adverse information. No securities were reported sold by the filer in the prior three months.
Positive
- Full compliance disclosure: The filer provides required Rule 144 details including broker, dates, amounts, and attestations.
- Traceable acquisition history: All 4,612 shares are broken down by grant date and shown as acquired via vesting, matching the total to be sold.
- No recent sales: The filer reports "Nothing to Report" for securities sold in the past three months, simplifying aggregation rules.
Negative
- None.
Insights
TL;DR: Routine insider sale filing: 4,612 shares (worth $133,932) scheduled for 09/05/2025; all shares originated from issuer stock awards.
This Form 144 is a standard compliance notice under Rule 144 documenting a proposed sale by an insider or affiliate. The size of the proposed sale is small relative to the issuer's total outstanding shares (4,612 vs 167,967,656). The acquisition details are transparent: all shares were received as stock awards on specific vesting dates and settled by vesting. No sales in the prior three months are reported, and the filer affirms no undisclosed material adverse information. From a market-impact perspective, this filing is informational and not, on its face, material to valuation.
TL;DR: Filing reflects routine insider compliance with disclosure rules; vesting schedule and broker are fully disclosed.
The document provides clear traceability of the securities to be sold, listing each grant date, amount, and that transfers arose from vesting. The use of a national broker (Merrill Lynch) and the signature/attestation language conform to regulatory requirements. The absence of recent sales reported in the prior three months simplifies aggregation calculations required under Rule 144. This filing supports transparent governance and adherence to insider trading disclosure protocols.